Continue Reading
Full article on CNBC
Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China
Market Intelligence Analysis
AI-Powered
Why This Matters
FDA chief Marty Makary is navigating the agency through a challenging period with staff and budget cuts, as well as changes to vaccine policy, amidst a backdrop of controversy.
Market Impact
Market impact analysis based on bearish sentiment with 75% confidence.
Sentiment
Bearish
AI Confidence
75%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping changes to vaccine policy.
Original article published by
CNBC
on February 19, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.